Sutro Biopharma to Present at the 44th Annual J.P. Morgan Healthcare Conference GlobeNewswire January 07, 2026 SOUTH SAN FRANCISCO, Calif., Jan. 07, 2026 (GLOBE NEWSWIRE) — Sutro Biopharma, Inc. (Sutro or the Company) (NASDAQ: STRO), a clinical-stage oncology company pioneering site-specific and novel-format antibody drug conjugates (ADCs), today announced that Jane Chung, Chief Executive Officer, […]

Krystal Biotech to Announce Interim Clinical Update from Highest Dose Cohort of Phase 1 CORAL-1 Study Evaluating KB407 in Patients with Cystic Fibrosis Investor call to be held January 8 at 4:30 pm ET to discuss data update and next steps GlobeNewswire January 07, 2026 PITTSBURGH, Jan. 07, 2026 (GLOBE NEWSWIRE) — Krystal Biotech, Inc.

INVESTOR DEADLINE NEXT WEEK: Robbins Geller Rudman & Dowd LLP announces that Firefly Aerospace Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit GlobeNewswire January 07, 2026 SAN DIEGO, Jan. 07, 2026 (GLOBE NEWSWIRE) — Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Firefly Aerospace Inc. (NASDAQ: FLY):

Ethan Allen Announces Release Date for its Fiscal 2026 Second Quarter Results GlobeNewswire January 07, 2026 DANBURY, CT, Jan. 07, 2026 (GLOBE NEWSWIRE) — Ethan Allen Interiors Inc. (“Ethan Allen” or the “Company”) (NYSE: ETD) will release its financial and operational results for the fiscal 2026 second quarter ended December 31, 2025, after the stock

Abivax Provides 2026 Corporate Outlook GlobeNewswire January 07, 2026 Abivax Provides 2026 Corporate Outlook New market insights indicate significant future expansion of the ulcerative colitis (UC) market, with obefazimod well positioned to become a future market leader in the IBD space ABTECT Phase 3 Data Safety Monitoring Board (DSMB) meeting on December 18, 2025, found

Turn Therapeutics Appoints Martin Dewhurst to its Board of Directors Mr. Dewhurst Brings Over 30 Years of Life Sciences and M&A Experience to the Board, Aligning with the Company's Strategic Long-Term Goals for Growth and Expansion GlobeNewswire January 07, 2026 LOS ANGELES, Jan. 07, 2026 (GLOBE NEWSWIRE) — Turn Therapeutics Inc. (Nasdaq: TTRX), a clinical-stage

Definitive Healthcare to Present at the 28th Annual Needham Growth Conference GlobeNewswire January 07, 2026 FRAMINGHAM, Mass., Jan. 07, 2026 (GLOBE NEWSWIRE) — Definitive Healthcare (Nasdaq: DH), an industry leader in healthcare market data and analytics, today announced that its Chief Financial Officer, Casey Heller, will present at the 28th Annual Needham Growth Conference. The

Crane NXT to Participate in the CJS Securities 26th Annual New Ideas for the New Year Conference GlobeNewswire January 07, 2026 WALTHAM, Mass., Jan. 07, 2026 (GLOBE NEWSWIRE) — Crane NXT, Co. (NYSE: CXT), a premier industrial technology company, announced that Aaron Saak, President and Chief Executive Officer, and Christina Cristiano, Senior Vice President and

(NASDAQ:DEFT), NEW YORK, Jan. 07, 2026 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of DeFi Technologies, Inc. (NASDAQ: DEFT) between May 12, 2025 and November 14, 2025, both dates inclusive (the “Class Period”), of the important January 30, 2026 lead plaintiff deadline. SO WHAT: If

(NASDAQ:PHAT), FLORHAM PARK, N.J., Jan. 07, 2026 (GLOBE NEWSWIRE) — Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a biopharmaceutical company focused on developing and commercializing novel treatments for gastrointestinal (GI) diseases, today announced certain preliminary unaudited financial results for the fourth quarter and full year ended December 31, 2025. Preliminary Fourth Quarter 2025 Financial Results For the